Skip to main content

Advertisement

Log in

Ovarian cancer survivors’ quality of life: a systematic review

  • Review
  • Published:
Journal of Cancer Survivorship Aims and scope Submit manuscript

Abstract

Purpose

The assessment of quality of life (QOL) among ovarian cancer (OC) patients has mainly focused on the acute phase of treatment. This systematic review examines studies measuring QOL in patients who survived OC after treatment and synthesizes results in order to assess QOL and patient-reported outcome (PRO) data at long-term follow-up.

Methods

Articles published in English between 1990 to November 2014 were identified with the databases MEDLINE and PubMed, using the specific keywords “OC survivors” combined with the terms, “QOL,” “health-related QOL,” and “PROs.” Data were reviewed for design, time since end of treatment, measurement tools, and outcomes (categorized in three topics: global QOL compared to controls, treatment sequelae, and intervention strategies).

Results

The initial search strategy provided 148 articles of which 31 were considered eligible. Most studies focused on epithelial OC, and only a few studies investigated survivors of ovarian germ cell tumor. More than 60 instruments of QOL measures were used in the corpus. Despite the persistence of psychological and physical symptoms, treatment sequelae, sexual problems, and fear of recurrence in some survivors, most studies demonstrated that OC survivors generally have good QOL compared to healthy women. Studies proposing interventions are lacking.

Conclusions and Implications for Cancer Survivor

OC survivors experience a wide range of sequelae that may persist for a long time and negatively impact QOL. Further large-scale research is needed to fully understand problems that have significant effects on QOL, in order to develop interventions and treatments suitable for women at need.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Les cancers en France en 2013. Collection État des lieux et des connaissances, ouvrage collectif édité par l’INCa, Boulogne-Billancourt, janvier 2014.

  2. Grosclaude P, Remontet L, Belot A, Danzon A, Rasamimanana-Cerf N, Bossard N. Survie des personnes atteintes de cancer en France, 1989-2007–Étude à partir des registres des cancers du réseau Francim. Saint-Maurice: Institut de veille sanitaire; 2013. 412 p. Available at: http://opac.invs.sante.fr/doc_num.php?explnum_id=8758. Accessed May 12, 2015.

    Google Scholar 

  3. Hess LM, Stehman FB. State of the science in ovarian cancer quality of life research: a systematic review. Int J Gynecol Cancer. 2012;22(7):1273–80.

    Article  PubMed  Google Scholar 

  4. Penson RT, Wenzel LB, Vergote I, et al. Quality of life considerations in gynecologic cancer. FIGO 6th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95, S247YS257.

    Article  Google Scholar 

  5. Sanders C, Egger M, Donovan J, et al. Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ. 1998;317:1191–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Lockwood-Rayermann S. Survivorship issues in ovarian cancer: a review. Oncol Nurs Forum. 2006;33(3):553–62.

    Article  PubMed  Google Scholar 

  7. Roland KB, Rodriguez JL, Patterson JR, Trivers KF. A literature review of the social and psychological needs of ovarian cancer survivors. Psychooncology. 2013;22(11):2408–18.

    Article  PubMed  Google Scholar 

  8. Smith HO, Berwick M, Verschraegen CF, Wiggins C, Lansing L, Muller CY, et al. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol. 2006;107:1075–85.

    Article  PubMed  Google Scholar 

  9. Williams S, Blessing JA, Liao S, Ball H, Hanjani P. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol. 1994;12:701–6.

    CAS  PubMed  Google Scholar 

  10. Swenson MM, MacLeod JS, Williams SD, Miller AM, Champion VL. Quality of life after among ovarian germ cell cancer survivors: a narrative analysis. Oncol Nurs Forum. 2003;30(3):380.

    Article  PubMed  Google Scholar 

  11. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–e34.

    Article  PubMed  Google Scholar 

  12. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(6), e1000097.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Matei D, Miller AM, Monahan P, Gershenson D, Zhao Q, Cella D, et al. Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study. J Clin Oncol. 2009;27(25):4142–9.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Monahan PO, Champion VL, Zhao Q, Miller AM, Gershenson D, Williams SD, et al. Case-control comparison of quality of life in long-term ovarian germ cell tumor survivors: a gynecologic oncology group study. J Psychosoc Oncol. 2008;26(3):19–42.

    Article  PubMed  Google Scholar 

  15. Gershenson DM, Miller AM, Champion VL, Monahan PO, Zhao Q, Cella D, et al. Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study. J Clin Oncol. 2007;25(19):2792–7.

    Article  PubMed  Google Scholar 

  16. Champion V, Williams SD, Miller A, Reuille KM, Wagler-Ziner K, Monahan PO, et al. Quality of life in long-term survivors of ovarian germ cell tumors: a Gynecologic Oncology Group study. Gynecol Oncol. 2007;105(3):687–94.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Ezendam NP, Pijlman B, Bhugwandass C, Pruijt JF, Mols F, Vos MC, et al. Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: results from the population-based PROFILES registry. Gynecol Oncol. 2014;135(3):510–7.

    Article  PubMed  Google Scholar 

  18. Teng FF, Kalloger SE, Brotto L, McAlpine JN. Determinants of quality of life in ovarian cancer survivors: a pilot study. J Obstet Gynaecol Can. 2014;36(8):708–15.

    Article  PubMed  Google Scholar 

  19. Stavraka C, Ford A, Ghaem-Maghami S, Crook T, Agarwal R, Gabra H, et al. A study of symptoms described by ovarian cancer survivors. Gynecol Oncol. 2012;125(1):59–64.

    Article  PubMed  Google Scholar 

  20. Paxton RJ, Garcia-Prieto C, Berglund M, Hernandez M, Hajek RA, Handy B, et al. A randomized parallel-group dietary study for stages II-IV ovarian cancer survivors. Gynecol Oncol. 2012;124(3):410–6.

    Article  PubMed  Google Scholar 

  21. Greimel E, Daghofer F, Petru E. Prospective assessment of quality of life in long-term ovarian cancer survivors. Int J Cancer. 2011;128(12):3005–11.

    Article  CAS  PubMed  Google Scholar 

  22. Mirabeau-Beale KL, Kornblith AB, Penson RT, Lee H, Goodman A, Campos SM, et al. Comparison of the quality of life of early and advanced stage ovarian cancer survivors. Gynecol Oncol. 2009;114(2):353–9.

    Article  PubMed  Google Scholar 

  23. Stevinson C, Tonkin K, Capstick V, Schepansky A, Ladha AB, Valance JK, et al. A population-based study of the determinants of physical activity in ovarian cancer survivors. J Phys Act Health. 2009;6(3):339–46.

    Article  PubMed  Google Scholar 

  24. Stevinson C, Capstick V, Schepansky A, Tonkin K, Vallance JK, Ladha AB, et al. Physical activity preferences of ovarian cancer survivors. Psycho-Oncology. 2009;18(4):422–8.

    Article  PubMed  Google Scholar 

  25. Stevinson C, Steed H, Faught W, Tonkin K, Vallance JK, Ladha AB, et al. Physical activity in ovarian cancer survivors: associations with fatigue, sleep, and psychosocial functioning. Int J Gynecol Cancer. 2009;19(1):73–8.

    Article  PubMed  Google Scholar 

  26. Stevinson C, Faught W, Steed H, Tonkin K, Ladha AB, Vallance JK, et al. Associations between physical activity and quality of life in ovarian cancer survivors. Gynecol Oncol. 2007;106(1):244–50.

    Article  PubMed  Google Scholar 

  27. Liavaag AH, Dørum A, Fosså SD, Tropé C, Dahl AA. Morbidity associated with “self-rated health” in epithelial ovarian cancer survivors. BMC Cancer. 2009;9:2.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Liavaag AH, Dørum A, Bjøro T, Oksefjell H, Fosså SD, Tropé C, et al. A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach. Gynecol Oncol. 2008;108(2):348–54.

    Article  PubMed  Google Scholar 

  29. Liavaag AH, Dorum A, Fossa SD, Tropé C, Dahl AA. Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones? J Clin Oncol. 2007;25:2049–56.

    Article  PubMed  Google Scholar 

  30. Fox SW, Lyon D. Symptom clusters and quality of life in survivors of ovarian cancer. Cancer Nurs. 2007;30(5):354–61.

    Article  PubMed  Google Scholar 

  31. Ferrell B, Cullinane CA, Ervine K, Melancon C, Uman GC, Juarez G. Perspectives on the impact of ovarian cancer: women’s views of quality of life. Oncol Nurs Forum. 2005;32(6):1143–9.

    Article  PubMed  Google Scholar 

  32. Stewart DE, Wong F, Duff S, Melancon CH, Cheung AM. “What doesn’t kill you makes you stronger”: an ovarian cancer survivor survey. Gynecol Oncol. 2001;83(3):537–42.

    Article  CAS  PubMed  Google Scholar 

  33. Matulonis UA, Kornblith A, Lee H, Bryan J, Gibson C, Wells C, et al. Long-term adjustment of early-stage ovarian cancer survivors. Int J Gynecol Cancer. 2008;18(6):1183–93.

    Article  CAS  PubMed  Google Scholar 

  34. Wenzel LB, Donnelly JP, Foweler JM, Habbal R, Taylor TH, Aziz N, et al. Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study. Psycho-Oncology. 2002;11:142–53.

    Article  PubMed  Google Scholar 

  35. Gross AH, Cromwell J, Fonteyn M, Matulonis UA, Hayman LL. Hopelessness and complementary therapy use in patients with ovarian cancer. Cancer Nurs. 2013;36(4):256–64.

    Article  PubMed  Google Scholar 

  36. Andersen MR, Sweet E, Lowe KA, Standish LJ, Drescher CW, Goff BA. Involvement in decision-making about treatment and ovarian cancer survivor quality of life. Gynecol Oncol. 2012;124(3):465–70.

    Article  PubMed  Google Scholar 

  37. Kornblith AB, Mirabeau-Beale K, Lee H, Goodman AK, Penson RT, Pereira L, et al. Long-term adjustment of survivors of ovarian cancer treated for advanced-stage disease. J Psychosoc Oncol. 2010;28(5):451–69.

    Article  PubMed  Google Scholar 

  38. Otis-Green S, Ferrell B, Sun V, Spolum M, Morgan R, Macdonald D. Feasibility of an ovarian cancer quality-of-life psychoeducational intervention. J Cancer Educ. 2008;23(4):214–21.

    Article  PubMed  Google Scholar 

  39. Holzner B, Kemmler G, Meraner V, Maislinger A, Kopp M, Bodner T, et al. Fatigue in ovarian carcinoma patients: a neglected issue? Cancer. 2003;97(6):1564–72.

    Article  PubMed  Google Scholar 

  40. Ferrel B, Smith SL, Cullinane CA, Melancon C. Psychological well-being and quality of life in ovarian cancer survivors. Cancer. 2003;98:1061–71.

    Article  Google Scholar 

  41. Ferrell BR, Smith SL, Juarez G, Melancon C. Meaning of illness and spirituality in ovarian cancer survivors. Oncol Nurs Forum. 2003;30(2):249–57.

    Article  PubMed  Google Scholar 

  42. Ersek M, Ferrell BR, Dow KH, Melancon CH. Quality of life in women with ovarian cancer. West J Nurs Res. 1997;19(3):334–50.

    Article  CAS  PubMed  Google Scholar 

  43. FACIT: view questionnaires and availability. Available at http://www.facit.org/FACITOrg/Questionnaires. Accessed April 28, 2015

  44. Basen-Engquist K, Bodurka-Bevers D, Fitzgerald MA, et al. Reliability and validity of the functional assessment of cancer therapy—ovarian. J Clin Oncol. 2001;19:1809–17.

    CAS  PubMed  Google Scholar 

  45. Ferrell B, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res. 1995;4(6):523–31.

    Article  CAS  PubMed  Google Scholar 

  46. Waterhouse J, Metcalfe MC. Development of the sexual adjustment questionnaire. Oncol Nurs Forum. 1986;13:53–9.

    CAS  PubMed  Google Scholar 

  47. Zeltzer LK, Lu Q, Leisenring W, et al. Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev. 2008;17(2):435–46.

    Article  PubMed  Google Scholar 

  48. Ashing-Giwa KT, Tejero JS, Kim J, Padilla GV, Hellemann G. Examining predictive models of HRQOL in a population-based, multiethnic sample of women with breast carcinoma. Qual Life Res. 2007;16(3):413–28.

    Article  PubMed  Google Scholar 

  49. Sweeney C, Schmitz KH, Lazovich D, Virnig BA, Wallace RB, Folsom AR. Functional limitations in elderly female cancer survivors. J Natl Cancer Inst. 2006;98(8):521–9.

    Article  PubMed  Google Scholar 

  50. Carmack Taylor CL, Basen-Engquist K, Shinn EH, Bodurka DC. Predictors of sexual functioning in ovarian cancer patients. J Clin Oncol. 2004;22:881–9.

    Article  PubMed  Google Scholar 

  51. Brotto LA, Heiman JR. Mindfulness in sex therapy: applications for women with sexual difficulties following gynecologic cancer. Sex Relationship Ther. 2007;22:1468–994.

    Google Scholar 

  52. Andersen BL. Psychological interventions for cancer patients to enhance the quality of life. J Consult Clin Psychol. 1992;60:552.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Weis J. Support groups for cancer patients. Support Care Cancer. 2003;11:63–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Ahmed-Lecheheb.

Ethics declarations

This article does not contain any studies with human participants or animals performed by any of the authors.

Conflict of interest

The authors declare that they have no conflict of interest. No significant financial support for this work was received that could have influenced its outcome.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahmed-Lecheheb, D., Joly, F. Ovarian cancer survivors’ quality of life: a systematic review. J Cancer Surviv 10, 789–801 (2016). https://doi.org/10.1007/s11764-016-0525-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11764-016-0525-8

Keywords

Navigation